SARC016: Phase II study of everolimus in combination with bevacizumab in sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors (MPNST).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Brigitte C. Widemann, Christian Frederick Meyer, Gregory Michael Cote, Rashmi Chugh, Mohammed M. Milhem, Brian Andrew Van Tine, AeRang Kim, Brian Turpin, Eva Dombi, Nalini Jayaprakash, Scott H. Okuno, Lee J. Helman, Ndidi Onwudiwe, Seth M. Steinberg, Denise K. Reinke, Karen Cichowski, John Peter Perentesis
Institutions: National Cancer Institute, Center for Cancer Research, Johns Hopkins University, Johns Hopkins Hospital, Massachusetts General Hospital, Michigan Medicine, University of Iowa Hospitals and Clinics, University of Iowa Health Care, University of Iowa Holden Comprehensive Cancer Center, Washington University in St. Louis, Cincinnati Children's Hospital Medical Center, National Institutes of Health, Mayo Clinic, Sarcoma Alliance for Research through Collaboration, Brigham and Women's Hospital
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890603937